NCT03362593View on ClinicalTrials.gov

A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

PHASE1TerminatedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

May 11, 2020

Study Completion Date

May 11, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

MEDI7219

Experimental Drug

DRUG

Placebo

Placebo

DRUG

Formulation without Active Drug

Formulation without Active Drug

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY